Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Vistin Pharma ASA: Mandatory notification of trade
By: GlobeNewswire - 31 May 2023Back to overview list

Magnus Tolleshaug, Chief Commercial Officer in Vistin Pharma ASA, and a primary insider, has on 31st of May 2023 purchased 15.000 shares in Vistin Pharma ASA at an average price of NOK 24,01 per share. Following this purchase Magnus Tolleshaug holds 35.000 shares in Vistin Pharma ASA.


Attachment


Copyright 2023 GlobeNewswire Back to overview list
to the top ↑